Transcriptomic Heterogeneity of Favorable-risk Prostate Cancer: Time To Move Past Cancer of the Prostate Risk Assessment (CAPRA) to Clinical-genomic Risk

Daniel E. Spratt, Edward M. Schaeffer*

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)453-454
Number of pages2
JournalEuropean urology
Volume74
Issue number4
DOIs
StatePublished - Oct 2018

ASJC Scopus subject areas

  • Urology

Cite this